Table 5.
Clinical characteristics of LVAD patients.
| Clinical characteristic, ID | LVAD normal RV function 1, 733252 | LVAD normal RV function 2, 233587 | LVAD milds RHF 1, 537114 | LVAD mild RHF 2, 203056 | LVAD severe RHF 1, 371558 | LVAD severe RHF 2, 956256 |
|---|---|---|---|---|---|---|
| Age | 61 | 65 | 48 | 51 | 36 | 64 |
| Sex | Male | Male | Male | Male | Male | Male |
| Ethnicity | African American | Caucasian | East Indian | African American | African American | Caucasian |
| Cause of HF | ICM | ICM | NICM, Viral | NICM | NICM, Viral | ICM |
| Received transplant | Yes | Yes | Yes | Yes | Yes | Yes |
| Diagnostic criteria RVF (INTERMACS) CVP > 18 mmHg with CI < 2.0 L/min | No | No | No | No | Yes | No |
| PCWP < 18 mmHg with Tamponade, VT, PnTx | No | No | No | No | No | No |
| RVAD, iNO, Inotrope > 1 week post LVAD | No | No | Yes, inotrope < 1 month | Yes, inotrope < 1 month | Yes, inotrope > 1 month | Yes, inotrope > 1 month |
| Severity criteria RVF (INTERMACS) | ||||||
| Severe: RVAD implanted | No | No | No | No | No | No |
| Moderate: Inotrope or iNO | No | No | No | No | Yes | Yes |
| Mild: (> 2 of the following) | No | No | Yes | Yes | NA | NA |
| CVP or RAP > 18 mmHg | No | No | No | No | No | No |
| CI < 2.3 L/min/m2 | Yes | No | No | No | Yes | No |
| Ascites or evidence significant peripheral edema | No | No | Yes | Yes | No | Yes |
| Increased CVP by echo (dilated IVC) or exam (increased JVP) | No | No | Yes | Yes | Yes | Yes |
CI: cardiac index; CVP: central venous pressure, HF: heart failure; ICM: ischemic cardiomyopathy, ID: identification number, iNO: inhaled nitric oxide; INTERMACS: Interagency Registry for Mechanically Assisted Circulatory Support; IVC: inferior vena cava; JVP: jugular venous pressure; LVAD: left ventricular assist device; NICM: non-ischemic cardiomyopathy; PCWP: pulmonary capillary wedge pressure, PnTx: Pneumothorax, RAP: right atrial pressure, RVAD: right ventricular assist device, VT: ventricular tachycardia.